Recurrent ovarian cancer in the era of poly-ADP ribose polymerase inhibitors: time to re-assess established clinical practices

M. Bartoletti & S. Pignata et al. · 2021-04-27

Journal
ESMO Open
Authors
M. Bartoletti, S.C. Cecere, L. Musacchio, R. Sorio, F. Puglisi, S. Pignata